The Myth Of Small-Cap Outperformance

Oppenheim Bernhard/DigitalVision via Getty Images The claim that small-cap stocks outperform large-cap stocks has too often been accepted as a factual statement by the investment community. This well-established characteristic of stock returns has even earned itself an enduring place in academic literature, also widely referred to as the “size” factor. The most cited academic literature…

Read More

Simpson Manufacturing Co., Inc. (SSD) Q1 2024 Earnings Call Transcript

Simpson Manufacturing Co., Inc. (NYSE:SSD) Q1 2024 Earnings Conference Call April 22, 2024 5:00 PM ET Company Participants Kim Orlando – ADDO Investor RelationsMike Olosky – President & Chief Executive OfficerBrian Magstadt – Chief Financial Officer Conference Call Participants Daniel Moore – CJS SecuritiesTim Wojs – BairdKurt Yinger – D.A. Davidson Operator Greetings. Welcome to…

Read More

Calix Q1: Sell On Weak Outlook Amid Persistent Business Headwinds (NYSE:CALX)

Yuri_Arcurs/E+ via Getty Images On Monday, Broadband services platform provider Calix, Inc. or “Calix” (NYSE:CALX) reported Q1/2024 results in line with the guidance provided by management in the Q4/2023 stockholder letter: Regulatory Filings While revenues and profitability were down both sequentially and year-over-year, gross margins reached new all-time highs. In addition, the company continued to…

Read More

SAP SE (SAP) Q1 2024 Earnings Call Transcript

SAP SE (NYSE:SAP) Q1 2024 Earnings Call Transcript April 22, 2024 5:00 PM ET Company Participants Anthony Coletta – Chief Investor Relations OfficerChristian Klein – Chief Executive OfficerDominik Asam – Chief Financial OfficerScott Russell – President, Customer Success Conference Call Participants Toby Ogg – JP Morgan Cazenove LimitedAdam Wood – Morgan StanleyJohannes Schaller – Deutsche…

Read More

Cathay General Bancorp (CATY) Q1 2024 Earnings Call Transcript

Cathay General Bancorp (NASDAQ:CATY) Q1 2024 Earnings Conference Call April 22, 2024 6:00 PM ET Company Participants Georgia Lo – Investor RelationsChang Liu – President and Chief Executive OfficerHeng Chen – Executive Vice President, Chief Financial Officer and Treasurer Conference Call Participants Matthew Clark – Piper SandlerBrandon King – Truist SecuritiesGary Tenner – D.A. DavidsonAndrew…

Read More

Snap-On: A Good Buy Post The Recent Correction (NYSE:SNA)

jetcityimage Investment Thesis I last covered Snap-on (NYSE:SNA) in October last year. While the company was doing alright for some time, the stock has given up most of its gains after its recent earnings release. Snap-on Incorporated faced challenges related to customer demand changes, especially in its Tools business last quarter. However, I believe we…

Read More

Reynolds Foundation Donates $1 Million To Fund Bitcoin And Open-source Projects

OpenSats, a non-profit organization that supports the development of free and open-source software and projects focusing on Bitcoin, announced today that it has received a $1,000,000 donation from the Reynolds Foundation.  OPENSATS RECEIVES $1,000,000 DONATION FROM REYNOLDS FOUNDATION The Reynolds Foundation is supporting OpenSats with a generous $1M donation, noting that they "warmly invite fellow philanthropists to…

Read More

Camtek: Potential Threat From Emerging China Chip Tool Market

kokouu/E+ via Getty Images Camtek (NASDAQ:CAMT) is an Israeli company that designs and manufactures high-end inspection and measurement equipment for semiconductor businesses. As such, 84% of its revenues as of FY 2023 have come from China, Taiwan, and South Korea, three countries where semiconductor productions are concentrated. CAMT went public in 2000 at $6 per…

Read More

Bitcoin is Borderless: How Decentralization and Permissionless Grant Autonomy Across Political Jursidictions

Bitcoin is an ephemeral digital currency. It doesn’t have a physical address, or a specific place you can track it down. It’s everywhere. This is what gives Bitcoin its superpowers, what makes it a truly decentralized and globally accessible monetary network. Your bitcoin isn’t stored in your wallet but at Bitcoin addresses recorded by every…

Read More

Goldman Sachs Q1: I See A Turnaround (NYSE:GS)

Dan Totilca Investment Thesis I believe post Q1 report, Goldman Sachs (NYSE:GS) has reoriented their corporate strategy once again emphasizing investment banking, and sales & trading, the places that the bank built its reputation. This is reflected in the bank’s substantial earnings beat for Q1 2024, with earnings per share coming in at $11.58, and…

Read More

Joint Stock Company Kaspi.kz (KSPI) Q1 2024 Earnings Call Transcript

Joint Stock Company Kaspi.kz (OTC:KSPI) Q1 2024 Earnings Conference Call April 22, 2024 8:00 AM ET Company Participants David Ferguson – Managing Director, Head of Investor RelationsMikheil Lomtadze – Co-Founder and CEO Conference Call Participants Darrin Peller – Wolfe ResearchGabor Kemeny – Autonomous ResearchJames Friedman – SIGReggie Smith – JPMorgan Operator Hello, everyone, and welcome…

Read More

Higher Bar For U.S. Earnings To Deliver

Matteo Colombo Transcript We saw 2024 as a year of two stories: First, cooling inflation and strong earnings would support upbeat risk appetite. Next, inflation would rollercoaster back up and disrupt sentiment. Recent inflation data suggest inflation isn’t cooling as quickly as we expected, implying that the second phase may be happening now. We think…

Read More

A Rant Against Ordinals

On Free Speech President of Bitcoin Magazine, Mike Germano, has dared me to publish this rant with the following meme: Source: https://x.com/mikegermano/status/1773003239312503243?s=20 To all the haters, yes, even in Bitcoin Magazine can free debate flourish. I’m grateful for the opportunity to submit a dissenting opinion about Ordinals. With technical editor Shinobi at the helm, writers’…

Read More

Swiss Central Bank Urged to Add Bitcoin to Balance Sheet

A group of Bitcoin advocates in Switzerland have launched a campaign to convince the Swiss National Bank (SNB) to add Bitcoin to its balance sheet.  The nonprofit organization 2B4CH aims to hold a national referendum to amend Switzerland’s constitution to require the central bank to hold Bitcoin. BREAKING: 🇨🇭Bitcoiners to launch a petition for Swiss…

Read More

Petrobras: We Shouldn’t Be Unnerved By The Overblown Dividend Crisis (NYSE:PBR)

FabioIm Petróleo Brasileiro S.A. (NYSE:PBR) investors endured a torrid two months as they dealt with the uncertainties emanating from Petrobras’s extraordinary dividend payout. As a reminder, the government seems displeased with paying these dividends to shareholders. Still, the irony is that the Brazilian government also needs the payout to support its fiscal budget. Moreover, the…

Read More

Very Bad News For Realty Income

Martin Barraud Lately, I have written a few negative articles on Realty Income (NYSE:O) and this has led some of its bulls to label me as a “hater”. But the reality is that I have no dog in this race. I am not shorting Realty Income, and I don’t stand to benefit in any way…

Read More

Why Aritzia Remains A Buy In Today’s Market (ATZAF)

JHVEPhoto Aritzia’s business fundamentals have improved since my previous analysis in March 2023 and its 2027 expansion plan is being well executed so far. I will evaluate in more details below how Aritzia has performed financially and in each of Aritzia’s core strategies in the past year. However, Aritzia’s valuation has declined significantly by over…

Read More

PFIX: Good Product But Risky Part Of Cycle

Montes-Bradley With hindsight, the trade of the cycle was to short long duration Treasuries on surging interest rates due to the fastest rate hike cycle in history. And certain products, like the Simplify Interest Rate Hedge ETF (NYSEARCA:PFIX), really thrived in terms of not just the timing of their launch, but performance, execution, and assets…

Read More

INmune Bio: An Opportunity In The Freefall (NASDAQ:INMB)

picturegarden/DigitalVision via Getty Images Topline Summary and Update INmune Bio (NASDAQ:INMB) is a company focused on developing drugs in two different disease areas: neurology and cancer medicine. I’ve previously covered this company in two articles, and I was a cautious optimist in my latest outing, with main reservations related to their cash burn rate and…

Read More

Microsoft: Timely Selloff Creates An Attractive Setup Ahead Of Q3 Earnings (NASDAQ:MSFT)

wdstock It’s been a rough couple of weeks in the markets leading into big-tech earnings season, as the macroeconomic backdrop is becoming increasingly negative, taking AI-mania’s spot in the center of attention. Microsoft (NASDAQ:MSFT), one of the leaders of the AI craze, is set to report its fiscal third-quarter results this Thursday, April 25th. Investors…

Read More

Eli Lilly And The Alzheimer’s Dilemma (NYSE:LLY)

fotoVoyager/E+ via Getty Images The Food and Drug Administration’s approval of Eli Lilly’s (NYSE:LLY) anti-amyloid antibody drug donanemab was once considered a slam dunk (previous analysis). But now, the FDA is convening an advisory panel to weigh in on the drug. This may just be a blip for Eli Lilly, or alternatively, concerns over donanemab’s…

Read More